Flashpoint Therapeutics, Inc.
Records under this name other than the patents Flashpoint Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 4 of 4 · Back to Flashpoint Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,123,294 | Multivalent Delivery of Immune Modulators by Liposomal Spherical Nucleic Acids for Prophylactic or Therapeutic Applications Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,434,064 | Multivalent Delivery of Immune Modulators by Liposomal Spherical Nucleic Acids for Prophylactic or Therapeutic Applications Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,957,788 | Multivalent Delivery of Immune Modulators by Liposomal Spherical Nucleic Acids for Prophylactic or Therapeutic Applications Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,760,080 | Anti-TNF compounds Lapsed on the fee record Ended Sep 1, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 1, 2024 | From the USPTO record |